Comparison between idiopathic and VEXAS-relapsing polychondritis: analysis of a French case series of 95 patients
Vincent Jachiet,
Benjamin Terrier,
Laurence Bouillet,
Claire de Moreuil,
Joris Galland,
Mathilde Devaux,
Mathieu Gerfaud-Valentin,
Alexandre Maria,
Jean Schmidt,
Sylvain Audia,
Guillaume Denis,
Mohamed-Yacine Khitri,
Alexis F Guedon,
Maelle le Besnerais,
Jean Sebastien Allain,
Vincent Grobost,
Olivier Kosmider,
Anael Dumont,
Benjamin Subran,
Paola Marianetti-Guingel,
Sylvain Palat,
Marielle Roux-Sauvat,
Pierre Hirsch
Affiliations
Vincent Jachiet
Hopital Saint-Antoine Service de Medecine Interne, Paris, Île-de-France, France
Benjamin Terrier
National Referral Center for Rare Systemic Autoimmune Diseases, Université Paris Descartes, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France
Laurence Bouillet
Internal Medicine, Centre Hospitalier Universitaire Grenoble, Michallon Hospital, Grenoble, France
Claire de Moreuil
Service de Médecine Interne, CHRU de Brest, Brest, France
Joris Galland
Hospital Centre Fleyriat de Bourg-en-Bresse, Bourg-en-Bresse, Rhône-Alpes, France
Mathilde Devaux
Intermunicipal Hospital Centre Poissy-Saint-Germain-en-Laye Poissy Site, Poissy, Île-de-France, France
Mathieu Gerfaud-Valentin
University Hospital Centre Lyon, Lyon, Auvergne-Rhône-Alpes, France
Alexandre Maria
Internal Medicine & Immuno-Oncology (MedI2O), CHU Montpellier, Montpellier, France
Jean Schmidt
Internal Medicine, Amiens University Hospital, Amiens, France
Sylvain Audia
CHU Dijon, Dijon, Bourgogne, France
Guillaume Denis
Centre Hospitalier de Rochefort, Rochefort, Nouvelle-Aquitaine, France
Mohamed-Yacine Khitri
Hopital Saint-Antoine Service de Medecine Interne, Paris, Île-de-France, France
Alexis F Guedon
Sorbonne Université,Service de Médecine Interne and Inflammation-Immunopathology-Biotherapy Department (DMU 3iD), Hôpital Saint-Antoine, AP-HP, Paris, France
Maelle le Besnerais
Hôpital Charles Nicolle, Rouen, Normandy, France
Jean Sebastien Allain
CHU Rennes, Rennes, Bretagne, France
Vincent Grobost
CHU Clermont-Ferrand, Clermont-Ferrand, France
Olivier Kosmider
Service d’Hématologie Biologique, DMU BioPhyGen, APHP, Paris, Île-de-France, France
Anael Dumont
CHU Caen, Caen, Basse-Normandie, France
Benjamin Subran
Hôpital de la Croix Saint-Simon, Paris, Île-de-France, France
Paola Marianetti-Guingel
CHU Reims, Reims, Champagne-Ardenne, France
Sylvain Palat
CHU Limoges, Limoges, Limousin, France
Marielle Roux-Sauvat
Service de médecine interne, Pierre Oudot Hospital of Bourgoin-Jallieu, Bourgoin-Jallieu, Rhône-Alpes, France
Pierre Hirsch
service d’hématologie biologique, Hôpital Saint-Antoine, Paris, Île-de-France, France
Objective A new adult-onset autoinflammatory syndrome has been described, named VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic). We aimed to compare the clinical characteristics, the laboratory features and the outcomes between idiopathic-relapsing polychondritis (I-RP) and VEXAS-relapsing polychondritis (VEXAS-RP).Methods Patients from French retrospective multicentre cohort of RP were separated into two groups: a VEXAS-RP and an I-RP.Results Compared with patients with I-RP (n=40), patients with VEXAS-RP (n=55) were men (96% vs 30%, p<0.001) and were older at diagnosis (66 vs 44 years, p<0.001). They had a greater prevalence of fever (60% vs 10%, p<0.001), of skin lesions (82% vs 20%, p<0.001), of ocular involvement (57% vs 28%, p=0.01), of pulmonary infiltrates (46% vs 0%, p<0.001), of heart involvement (11% vs 0%, p=0.0336) and with higher median C-reactive protein levels (64 mg/L vs 10 mg/L, p<0.001). Seventy-five per cent of the patients with VEXAS-RP had myelodysplastic syndrome (MDS) versus none in I-RP group. The glucocorticoids use, and the number of steroid sparing agents were similar in both groups, but patients with VEXAS-RP had more frequent refractory disease (remission obtained in 27% vs 90%, p<0001). VEXAS-RP was associated with higher risk of death: six patients (11%) died in the VEXAS-RP group after a median follow-up of 37 months and none in the I-RP group after a median follow-up of 92 months (p<0.05).Conclusion We report the largest cohort of VEXAS-RP, characterised by high prevalence of male sex, fever, skin lesion, ocular involvement, pulmonary infiltration, heart involvement, older age and MDS association.